{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:30:41Z","timestamp":1794587441723,"version":"4.9.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jchf.2024.02.014","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:54:43Z","timestamp":1712174083000},"page":"1059-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["National Trends in Hospital Performance\u00a0in Guideline-Recommended Pharmacologic Treatment for Heart\u00a0Failure at Discharge"],"prefix":"10.1016","volume":"12","author":[{"given":"Paul L.","family":"Hess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Langner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4494-5028","authenticated-orcid":false,"given":"Utibe","family":"Essien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3736-7434","authenticated-orcid":false,"given":"Stanley A.","family":"Swat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Polsinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary K.","family":"Grunwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Michael","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jchf.2024.02.014_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-157-3-201208070-00012","article-title":"Implementing the learning health system: from concept to action","volume":"157","author":"Greene","year":"2012","journal-title":"Ann Intern Med"},{"issue":"14","key":"10.1016\/j.jchf.2024.02.014_bib2","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1161\/CIR.0000000000000480","article-title":"The learning healthcare system and cardiovascular care: a scientific statement from the American Heart Association","volume":"135","author":"Maddox","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jchf.2024.02.014_bib3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jchf.2024.02.014_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.jchf.2024.02.014_bib5","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2012.03.013","volume":"59","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jchf.2024.02.014_bib6","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.jacc.2020.07.023","article-title":"2020 ACC\/AHA clinical performance and quality measures for adults with heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"76","author":"Heidenreich","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.02.014_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-publhealth-031816-044255","article-title":"Moving from discovery to system-wide change: the role of research in a learning health care system: experience from three decades of health systems research in the Veterans Health Administration","volume":"38","author":"Atkins","year":"2017","journal-title":"Annu Rev Public Health"},{"issue":"6","key":"10.1016\/j.jchf.2024.02.014_bib8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/CIRCOUTCOMES.115.002542","article-title":"Guideline-appropriate care and in-hospital outcomes in patients with heart failure in teaching and nonteaching hospitals: findings from Get With the Guidelines\u2013Heart Failure","volume":"9","author":"Patel","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"14","key":"10.1016\/j.jchf.2024.02.014_bib9","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/CIRCULATIONAHA.115.014281","article-title":"Medication initiation burden required to comply with heart failure guideline recommendations and hospital quality measures","volume":"132","author":"Allen","year":"2015","journal-title":"Circulation"},{"issue":"8 Pt 1","key":"10.1016\/j.jchf.2024.02.014_bib10","first-page":"918","article-title":"Opportunities and achievement of medication initiation among inpatients with heart failure with reduced ejection fraction","volume":"11","author":"Swat","year":"2023","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"1","key":"10.1016\/j.jchf.2024.02.014_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12872-017-0580-8","article-title":"Unlocking echocardiogram measurements for heart disease research through natural language processing","volume":"17","author":"Patterson","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jchf.2024.02.014_bib13","first-page":"104","article-title":"From sour grapes to low-hanging fruit: a case study demonstrating a practical strategy for natural language processing portability","volume":"2017","author":"Johnson","year":"2018","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"key":"10.1016\/j.jchf.2024.02.014_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jbi.2017.01.017","article-title":"Extraction of left ventricular ejection fraction information from various types of clinical reports","volume":"67","author":"Kim","year":"2017","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.jchf.2024.02.014_bib15","series-title":"Facilities staffing requirements for the veterans health administration\u2014resource planning and methodology for the future","author":"Drury","year":"2020"},{"key":"10.1016\/j.jchf.2024.02.014_bib16","author":"Marks"},{"issue":"16","key":"10.1016\/j.jchf.2024.02.014_bib17","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jchf.2024.02.014_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12874-018-0517-7","article-title":"Reference effect measures for quantifying, comparing and visualizing variation from random and fixed effects in non-normal multilevel models, with applications to site variation in medical procedure use and outcomes","volume":"18","author":"Glorioso","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"10.1016\/j.jchf.2024.02.014_bib19","article-title":"Sex differences in oral anticoagulation and outcomes of stroke and intracranial bleeding in newly diagnosed atrial fibrillation","volume":"9","author":"Yong","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.jchf.2024.02.014_bib20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: should we use a CHA2DS2-VA score rather than CHA2DS2-VASc?","volume":"137","author":"Nielsen","year":"2018","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jchf.2024.02.014_bib21","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1001\/jamacardio.2022.3704","article-title":"Association of race and ethnicity with oral anticoagulation and associated outcomes in patients with atrial fibrillation: findings from the Get With the Guidelines\u2013Atrial Fibrillation registry","volume":"7","author":"Essien","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"7","key":"10.1016\/j.jchf.2024.02.014_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14234","article-title":"Disparities in anticoagulant therapy initiation for incident atrial fibrillation by race\/ethnicity among patients in the Veterans Health Administration system","volume":"4","author":"Essien","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"16","key":"10.1016\/j.jchf.2024.02.014_bib23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.121.054516","article-title":"Social vulnerability and premature cardiovascular mortality among US counties, 2014 to 2018","volume":"144","author":"Khan","year":"2021","journal-title":"Circulation"},{"issue":"8 Pt 1","key":"10.1016\/j.jchf.2024.02.014_bib24","first-page":"933","article-title":"Utilization rates of SGLT2 inhibitors among patients with type 2 diabetes, heart failure, and atherosclerotic cardiovascular disease: insights from the Department of Veterans Affairs","volume":"11","author":"Hussain","year":"2023","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"2","key":"10.1016\/j.jchf.2024.02.014_bib25","first-page":"161","article-title":"Treatment differences in medical therapy for heart failure with reduced ejection fraction between sociodemographic groups","volume":"11","author":"Witting","year":"2023","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"11","key":"10.1016\/j.jchf.2024.02.014_bib26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial\u00a0fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.jchf.2024.02.014_bib27","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.jchf.2024.02.014_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.jchf.2024.02.014_bib29","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jchf.2024.02.014_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924001781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924001781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T02:30:41Z","timestamp":1748745041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177924001781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2213177924001781"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2024.02.014","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"National Trends in Hospital Performance\u00a0in Guideline-Recommended Pharmacologic Treatment for Heart\u00a0Failure at Discharge","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2024.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}